TRPM7 regulates polarized cell movements

Li Ting Su, Wei Liu, Hsiang Chin Chen, Omayra González-PAGÁN, Raymond Habas, Loren W. Runnels

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

TRPM7 (transient receptor potential melastatin 7) is a Ca 2+-and Mg 2+-permeant ion channel in possession of its own kinase domain. As a kinase, the protein has been linked to the control of actomyosin contractility, whereas the channel has been found to regulate cell adhesion as well as cellular Mg 2+ homoeostasis. In the present study we show that depletion of TRPM7 by RNA interference in fibroblasts alters cell morphology, the cytoskeleton, and the ability of cells to form lamellipodia and to execute polarized cellmovements.Apulldown-purification assay revealed that knockdown of TRPM7 prevents cells from activating Rac and Cdc42 (cell division cycle 42) when stimulated to migrate into a cellular wound. Re-expression of TRPM7 reverses these phenotypic changes, as does, unexpectedly, expression of a kinaseinactive mutant of TRPM7. Surprisingly, expression of the Mg 2+ transporter SLC41A2 (solute carrier family 41 member 2) is also effective in restoring the change in cell morphology, disruption of the cytoskeleton and directional cell motility caused by depletion of the channel-kinase. The results of the present study uncover an essential role for Mg 2+ in the control of TRPM7 over the cytoskeleton and its ability to regulate polarized cell movements.

Original languageEnglish
Pages (from-to)513-521
Number of pages9
JournalBiochemical Journal
Volume434
Issue number3
DOIs
Publication statusPublished - 15 Mar 2011
Externally publishedYes

Fingerprint

Cell Movement
Cytoskeleton
Cells
Aptitude
Phosphotransferases
Actomyosin
Pseudopodia
RNA Interference
Ion Channels
Cell Adhesion
Protein Kinases
Cell Cycle
Homeostasis
Fibroblasts
Cell adhesion
Purification
Assays
Wounds and Injuries
RNA

Keywords

  • Cell morphology
  • Channel
  • Cytoskeleton
  • Magnesium
  • Polarized cell movement
  • Transient receptor potential melastatin 7 (TRPM7)

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Su, L. T., Liu, W., Chen, H. C., González-PAGÁN, O., Habas, R., & Runnels, L. W. (2011). TRPM7 regulates polarized cell movements. Biochemical Journal, 434(3), 513-521. https://doi.org/10.1042/BJ20101678

TRPM7 regulates polarized cell movements. / Su, Li Ting; Liu, Wei; Chen, Hsiang Chin; González-PAGÁN, Omayra; Habas, Raymond; Runnels, Loren W.

In: Biochemical Journal, Vol. 434, No. 3, 15.03.2011, p. 513-521.

Research output: Contribution to journalArticle

Su, LT, Liu, W, Chen, HC, González-PAGÁN, O, Habas, R & Runnels, LW 2011, 'TRPM7 regulates polarized cell movements', Biochemical Journal, vol. 434, no. 3, pp. 513-521. https://doi.org/10.1042/BJ20101678
Su LT, Liu W, Chen HC, González-PAGÁN O, Habas R, Runnels LW. TRPM7 regulates polarized cell movements. Biochemical Journal. 2011 Mar 15;434(3):513-521. https://doi.org/10.1042/BJ20101678
Su, Li Ting ; Liu, Wei ; Chen, Hsiang Chin ; González-PAGÁN, Omayra ; Habas, Raymond ; Runnels, Loren W. / TRPM7 regulates polarized cell movements. In: Biochemical Journal. 2011 ; Vol. 434, No. 3. pp. 513-521.
@article{746bc824be33479b8448add20d521594,
title = "TRPM7 regulates polarized cell movements",
abstract = "TRPM7 (transient receptor potential melastatin 7) is a Ca 2+-and Mg 2+-permeant ion channel in possession of its own kinase domain. As a kinase, the protein has been linked to the control of actomyosin contractility, whereas the channel has been found to regulate cell adhesion as well as cellular Mg 2+ homoeostasis. In the present study we show that depletion of TRPM7 by RNA interference in fibroblasts alters cell morphology, the cytoskeleton, and the ability of cells to form lamellipodia and to execute polarized cellmovements.Apulldown-purification assay revealed that knockdown of TRPM7 prevents cells from activating Rac and Cdc42 (cell division cycle 42) when stimulated to migrate into a cellular wound. Re-expression of TRPM7 reverses these phenotypic changes, as does, unexpectedly, expression of a kinaseinactive mutant of TRPM7. Surprisingly, expression of the Mg 2+ transporter SLC41A2 (solute carrier family 41 member 2) is also effective in restoring the change in cell morphology, disruption of the cytoskeleton and directional cell motility caused by depletion of the channel-kinase. The results of the present study uncover an essential role for Mg 2+ in the control of TRPM7 over the cytoskeleton and its ability to regulate polarized cell movements.",
keywords = "Cell morphology, Channel, Cytoskeleton, Magnesium, Polarized cell movement, Transient receptor potential melastatin 7 (TRPM7)",
author = "Su, {Li Ting} and Wei Liu and Chen, {Hsiang Chin} and Omayra Gonz{\'a}lez-PAG{\'A}N and Raymond Habas and Runnels, {Loren W.}",
year = "2011",
month = "3",
day = "15",
doi = "10.1042/BJ20101678",
language = "English",
volume = "434",
pages = "513--521",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - TRPM7 regulates polarized cell movements

AU - Su, Li Ting

AU - Liu, Wei

AU - Chen, Hsiang Chin

AU - González-PAGÁN, Omayra

AU - Habas, Raymond

AU - Runnels, Loren W.

PY - 2011/3/15

Y1 - 2011/3/15

N2 - TRPM7 (transient receptor potential melastatin 7) is a Ca 2+-and Mg 2+-permeant ion channel in possession of its own kinase domain. As a kinase, the protein has been linked to the control of actomyosin contractility, whereas the channel has been found to regulate cell adhesion as well as cellular Mg 2+ homoeostasis. In the present study we show that depletion of TRPM7 by RNA interference in fibroblasts alters cell morphology, the cytoskeleton, and the ability of cells to form lamellipodia and to execute polarized cellmovements.Apulldown-purification assay revealed that knockdown of TRPM7 prevents cells from activating Rac and Cdc42 (cell division cycle 42) when stimulated to migrate into a cellular wound. Re-expression of TRPM7 reverses these phenotypic changes, as does, unexpectedly, expression of a kinaseinactive mutant of TRPM7. Surprisingly, expression of the Mg 2+ transporter SLC41A2 (solute carrier family 41 member 2) is also effective in restoring the change in cell morphology, disruption of the cytoskeleton and directional cell motility caused by depletion of the channel-kinase. The results of the present study uncover an essential role for Mg 2+ in the control of TRPM7 over the cytoskeleton and its ability to regulate polarized cell movements.

AB - TRPM7 (transient receptor potential melastatin 7) is a Ca 2+-and Mg 2+-permeant ion channel in possession of its own kinase domain. As a kinase, the protein has been linked to the control of actomyosin contractility, whereas the channel has been found to regulate cell adhesion as well as cellular Mg 2+ homoeostasis. In the present study we show that depletion of TRPM7 by RNA interference in fibroblasts alters cell morphology, the cytoskeleton, and the ability of cells to form lamellipodia and to execute polarized cellmovements.Apulldown-purification assay revealed that knockdown of TRPM7 prevents cells from activating Rac and Cdc42 (cell division cycle 42) when stimulated to migrate into a cellular wound. Re-expression of TRPM7 reverses these phenotypic changes, as does, unexpectedly, expression of a kinaseinactive mutant of TRPM7. Surprisingly, expression of the Mg 2+ transporter SLC41A2 (solute carrier family 41 member 2) is also effective in restoring the change in cell morphology, disruption of the cytoskeleton and directional cell motility caused by depletion of the channel-kinase. The results of the present study uncover an essential role for Mg 2+ in the control of TRPM7 over the cytoskeleton and its ability to regulate polarized cell movements.

KW - Cell morphology

KW - Channel

KW - Cytoskeleton

KW - Magnesium

KW - Polarized cell movement

KW - Transient receptor potential melastatin 7 (TRPM7)

UR - http://www.scopus.com/inward/record.url?scp=79952177149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952177149&partnerID=8YFLogxK

U2 - 10.1042/BJ20101678

DO - 10.1042/BJ20101678

M3 - Article

VL - 434

SP - 513

EP - 521

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -